Open Access
Open access
Biomedicine and Pharmacotherapy, volume 143, pages 112158

A mini-review on the impact of COVID 19 on vital organs

Muhammad Raza Shah 1
Aini Simon Sumeh 2
Muhammad Ali Sheraz 3
Muthu Subash Kavitha 4
BALU ALAGAR VENMATHI MARAN 5
KENNETH FRANCIS RODRIGUES 6
Publication typeJournal Article
Publication date2021-11-01
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor7.5
ISSN07533322
General Medicine
Pharmacology
Abstract
COVID-19 (Corona Virus Disease-2019) is an infectious disease caused by a novel coronavirus, known as the acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This is a highly contagious disease that has already affected more than 220 countries globally, infecting more than 212 million people and resulting in the death of over 4.4 million people. This review aims to highlight the pertinent documentary evidence upon the adverse effects of the SARS-CoV-2 infection on several vital human organs. SARS-CoV-2 primarily targets the lung tissue by causing diffuse alveolar damage and may result in Acute Respiratory Distress Syndrome (ARDS). SARS-CoV-2 infects the cell via cell surface receptor, angiotensin-converting enzyme 2 (ACE2). Besides lungs, SARS-CoV-2 critically damage tissues in other vital human organs such as the heart, kidney, liver, brain, and gastrointestinal tract. The effect on the heart includes muscle dysfunction (acute or protracted heart failure), myocarditis, and cell necrosis. Within hepatic tissue, it alters serum aminotransferase, total bilirubin, and gamma-glutamyl transferase levels. It contributes to acute kidney injury (AKI). Localized infection of the brain can lead to loss or attenuation of olfaction, muscular pain, headaches, encephalopathy, dizziness, dysgeusia, psychomotor disorders, and stroke; while the gastrointestinal symptoms include the disruption of the normal intestinal mucosa, leading to diarrhea and abdominal pain. This review encompassed a topical streak of systemic malfunctions caused by the SARS-CoV-2 infection. As the pandemic is still in progress, more studies will enrich our understanding and analysis of this disease.

Top-30

Citations by journals

1
2
3
Journal of Clinical Medicine
3 publications, 8.57%
Biomolecules
2 publications, 5.71%
International Journal of Molecular Sciences
2 publications, 5.71%
International Journal of Environmental Research and Public Health
2 publications, 5.71%
Virology
1 publication, 2.86%
Healthcare
1 publication, 2.86%
Frontiers in Medicine
1 publication, 2.86%
Inflammation Research
1 publication, 2.86%
Bulletin of Experimental Biology and Medicine
1 publication, 2.86%
Kardiologicheskii vestnik
1 publication, 2.86%
Revista da Sociedade Brasileira de Medicina Tropical
1 publication, 2.86%
Journal of the American Heart Association
1 publication, 2.86%
Electrochimica Acta
1 publication, 2.86%
Frontiers in Immunology
1 publication, 2.86%
European Journal of Human Genetics
1 publication, 2.86%
Biomedicines
1 publication, 2.86%
Vaccines
1 publication, 2.86%
Health Science Reports
1 publication, 2.86%
IEEE Access
1 publication, 2.86%
QJM - Monthly Journal of the Association of Physicians
1 publication, 2.86%
International journal of nursing knowledge
1 publication, 2.86%
Infectious Disease Reports
1 publication, 2.86%
Diagnostics
1 publication, 2.86%
Russian Chemical Reviews
1 publication, 2.86%
Inflammopharmacology
1 publication, 2.86%
Journal of Nutrition, Health and Aging
1 publication, 2.86%
1
2
3

Citations by publishers

2
4
6
8
10
12
14
Multidisciplinary Digital Publishing Institute (MDPI)
14 publications, 40%
Springer Nature
5 publications, 14.29%
Wiley
3 publications, 8.57%
Elsevier
2 publications, 5.71%
Frontiers Media S.A.
2 publications, 5.71%
Cold Spring Harbor Laboratory
2 publications, 5.71%
Media Sphere Publishing Group
1 publication, 2.86%
Sociedade Brasileira de Medicina Tropical
1 publication, 2.86%
IEEE
1 publication, 2.86%
Oxford University Press
1 publication, 2.86%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 2.86%
2
4
6
8
10
12
14
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Shah M. R. et al. A mini-review on the impact of COVID 19 on vital organs // Biomedicine and Pharmacotherapy. 2021. Vol. 143. p. 112158.
GOST all authors (up to 50) Copy
Shah M. R., Sumeh A. S., Sheraz M. A., Kavitha M. S., MARAN B. A. V., RODRIGUES K. F. A mini-review on the impact of COVID 19 on vital organs // Biomedicine and Pharmacotherapy. 2021. Vol. 143. p. 112158.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.biopha.2021.112158
UR - https://doi.org/10.1016/j.biopha.2021.112158
TI - A mini-review on the impact of COVID 19 on vital organs
T2 - Biomedicine and Pharmacotherapy
AU - Shah, Muhammad Raza
AU - Sumeh, Aini Simon
AU - Sheraz, Muhammad Ali
AU - Kavitha, Muthu Subash
AU - MARAN, BALU ALAGAR VENMATHI
AU - RODRIGUES, KENNETH FRANCIS
PY - 2021
DA - 2021/11/01 00:00:00
PB - Elsevier
SP - 112158
VL - 143
SN - 0753-3322
ER -
BibTex
Cite this
BibTex Copy
@article{2021_Shah,
author = {Muhammad Raza Shah and Aini Simon Sumeh and Muhammad Ali Sheraz and Muthu Subash Kavitha and BALU ALAGAR VENMATHI MARAN and KENNETH FRANCIS RODRIGUES},
title = {A mini-review on the impact of COVID 19 on vital organs},
journal = {Biomedicine and Pharmacotherapy},
year = {2021},
volume = {143},
publisher = {Elsevier},
month = {nov},
url = {https://doi.org/10.1016/j.biopha.2021.112158},
pages = {112158},
doi = {10.1016/j.biopha.2021.112158}
}
Found error?